This is the authors' abstract. We don't add key points for this paper.
A novel mercury(II) polymer with pendant dipicolylamine (DPA) chelators carrying Hg 2+ ions was prepared as a potential mass tag for mass cytometry (MC) applications. The polymer itself, with DP ≈ 22 had a mixture of PEG 24 (provides stealth) and PEG 23 -azide groups attached to the pendant groups, with ca. 3 azide groups per polymer for antibody conjugation. The initial Hg–DPA complex had 2 Cl atoms attached to each Hg 2+ ion (Cl 2 –Hg–DPA). An approach to replace the two Hg–Cl bonds via ligand exchange reactions by treating the Hg–DPA polymer with monothiol ligands (glutathione, cysteine, and thioglycolic acid) led to a loss of Hg, while Hg polymers treated with dithiol ligands (2,3-dimercapto-1-propanol and 2,3-dimercapto-1-propanesulfonic acid sodium salt monohydrate) led to polymers 2d and 2f, respectively, in which both polymers largely retained their Hg content. These polymers showed relatively low levels of nonspecific binding to suspensions of peripheral blood mononuclear cells (PBMCs). Both polymers were conjugated to anti-CD8a via strain-promoted azide−alkyne coupling, and the conjugates were employed in a 10-plex assay of PBMCs along with Maxpar reagents. Polymer 2d-CD8a showed excellent specificity to target CD8a antigens, even at a low titer of 0.56 μg/mL, and the ability to differentiate CD8a T cells from other components of the PBMC sample. In contrast, polymer 2f-CD8a gave no Hg signal suggesting loss of Hg from the polymer during Ab conjugation or PBMC staining steps. Polymer 2d represents an important step forward in the development of Hg mass tags for MC.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wong et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: